Axert

Almotriptan · Eisai Co., Ltd.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Axert, covering 2011-05-17 to 2025-05-31. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine [Phase 4]